Kingworld Medicines Group Limited (1110.HK)
HKD 0.45
(1.12%)
HKD 0.45
(1.12%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 38.09 Million CNY | -12.51% |
| 2022 | 43.54 Million CNY | -14.98% |
| 2021 | 51.21 Million CNY | 0.63% |
| 2020 | 50.88 Million CNY | 17.18% |
| 2019 | 43.42 Million CNY | 5.91% |
| 2018 | 41 Million CNY | -19.69% |
| 2017 | 51.06 Million CNY | 8.72% |
| 2016 | 46.96 Million CNY | 50.51% |
| 2015 | 31.2 Million CNY | -17.59% |
| 2014 | 37.86 Million CNY | -19.74% |
| 2013 | 47.17 Million CNY | -2.8% |
| 2012 | 48.53 Million CNY | -4.89% |
| 2011 | 51.03 Million CNY | 19.06% |
| 2010 | 42.86 Million CNY | 15.09% |
| 2009 | 37.24 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 15.35 Million CNY | 8224.12% |
| 2024 Q2 | 15.35 Million CNY | 0.0% |
| 2023 FY | 38.09 Million CNY | -12.51% |
| 2023 Q4 | 184.5 Thousand CNY | 0.0% |
| 2023 Q1 | 18.86 Million CNY | 2662.98% |
| 2023 Q3 | 184.5 Thousand CNY | -99.02% |
| 2023 Q2 | 18.86 Million CNY | 0.0% |
| 2022 Q1 | 12.1 Million CNY | 123.43% |
| 2022 Q3 | -736 Thousand CNY | -106.08% |
| 2022 Q4 | -736 Thousand CNY | 0.0% |
| 2022 FY | 43.54 Million CNY | -14.98% |
| 2022 Q2 | 12.1 Million CNY | 0.0% |
| 2021 FY | 51.21 Million CNY | 0.63% |
| 2021 Q1 | 9.74 Million CNY | 944.05% |
| 2021 Q4 | 5.41 Million CNY | 0.0% |
| 2021 Q3 | 5.41 Million CNY | -44.37% |
| 2021 Q2 | 9.74 Million CNY | 0.0% |
| 2020 Q4 | 933 Thousand CNY | 0.0% |
| 2020 FY | 50.88 Million CNY | 17.18% |
| 2020 Q3 | 933 Thousand CNY | -81.06% |
| 2020 Q2 | 4.92 Million CNY | 0.0% |
| 2020 Q1 | 4.92 Million CNY | -6.56% |
| 2019 Q4 | 5.27 Million CNY | 0.0% |
| 2019 FY | 43.42 Million CNY | 5.91% |
| 2019 Q1 | 16.44 Million CNY | 144.37% |
| 2019 Q3 | 5.27 Million CNY | -67.94% |
| 2019 Q2 | 16.44 Million CNY | 0.0% |
| 2018 FY | 41 Million CNY | -19.69% |
| 2018 Q3 | 6.72 Million CNY | -51.15% |
| 2018 Q2 | 13.77 Million CNY | 0.0% |
| 2018 Q1 | 13.77 Million CNY | -4.75% |
| 2018 Q4 | 6.72 Million CNY | 0.0% |
| 2017 FY | 51.06 Million CNY | 8.72% |
| 2017 Q4 | 14.46 Million CNY | 0.0% |
| 2017 Q3 | 14.46 Million CNY | 30.65% |
| 2017 Q2 | 11.06 Million CNY | 0.0% |
| 2017 Q1 | 11.06 Million CNY | -17.57% |
| 2016 Q4 | 13.42 Million CNY | 0.0% |
| 2016 Q2 | 10.19 Million CNY | 0.0% |
| 2016 Q3 | 13.42 Million CNY | 31.77% |
| 2016 Q1 | 10.19 Million CNY | 40.16% |
| 2016 FY | 46.96 Million CNY | 50.51% |
| 2015 Q2 | 8.96 Million CNY | 0.0% |
| 2015 Q3 | 7.27 Million CNY | -18.92% |
| 2015 Q4 | 7.27 Million CNY | 0.0% |
| 2015 FY | 31.2 Million CNY | -17.59% |
| 2015 Q1 | 8.96 Million CNY | -2.8% |
| 2014 FY | 37.86 Million CNY | -19.74% |
| 2014 Q1 | 9.73 Million CNY | -31.72% |
| 2014 Q4 | 9.22 Million CNY | 0.0% |
| 2014 Q2 | 9.73 Million CNY | 0.0% |
| 2014 Q3 | 9.22 Million CNY | -5.26% |
| 2013 Q1 | 9.32 Million CNY | -35.38% |
| 2013 Q3 | 14.26 Million CNY | 52.89% |
| 2013 Q4 | 14.26 Million CNY | 0.0% |
| 2013 FY | 47.17 Million CNY | -2.8% |
| 2013 Q2 | 9.32 Million CNY | 0.0% |
| 2012 FY | 48.53 Million CNY | -4.89% |
| 2012 Q1 | 12.13 Million CNY | 0.0% |
| 2012 Q2 | 12.13 Million CNY | 0.0% |
| 2012 Q4 | 14.43 Million CNY | 0.0% |
| 2012 Q3 | 14.43 Million CNY | 18.96% |
| 2011 Q4 | 12.13 Million CNY | -4.89% |
| 2011 Q2 | 12.75 Million CNY | 0.0% |
| 2011 Q1 | 12.75 Million CNY | 0.0% |
| 2011 FY | 51.03 Million CNY | 19.06% |
| 2011 Q3 | 12.75 Million CNY | 0.0% |
| 2010 Q1 | 10.71 Million CNY | 0.0% |
| 2010 Q4 | 12.75 Million CNY | 19.06% |
| 2010 Q3 | 10.71 Million CNY | 0.0% |
| 2010 Q2 | 10.71 Million CNY | 0.0% |
| 2010 FY | 42.86 Million CNY | 15.09% |
| 2009 FY | 37.24 Million CNY | 0.0% |
| 2009 Q2 | 9.31 Million CNY | 0.0% |
| 2009 Q3 | 9.31 Million CNY | 0.0% |
| 2009 Q4 | 10.71 Million CNY | 15.09% |
| 2009 Q1 | 9.31 Million CNY | 0.0% |
| 2008 Q4 | 9.31 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| China Healthwise Holdings Limited | -134.55 Million HKD | 128.312% |
| Tycoon Group Holdings Limited | 297.31 Million HKD | 87.187% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 540.39 Million HKD | 92.95% |